The Epoch Times
The Epoch Times
Focus

Merck & Co

US
US
|
Reuters

FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment

Jul 28, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment
Jul 28
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US News
US News
|
Reuters

Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment

Dec 23, 2020
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment
Dec 23
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US
US
|
Reuters

FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment

Jul 28, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment
Jul 28
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US News
US News
|
Reuters

Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment

Dec 23, 2020
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment
Dec 23
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.